Cryoablation, a cutting-edge medical procedure, has emerged as a promising technique for treating various medical conditions, particularly in the realm of oncology. This minimally invasive procedure involves the use of extreme cold to destroy abnormal tissues, such as tumors or abnormal cells. During cryoablation, a probe is inserted into the targeted area, and a gas is released to create freezing temperatures, effectively forming an ice ball that engulfs the abnormal tissue. This process is advantageous for its precision, as it allows doctors to specifically target the affected area without causing extensive damage to surrounding healthy tissues. Cryoablation has gained popularity in the treatment of certain cancers, including prostate, kidney, and liver tumors, offering patients a less invasive alternative to traditional surgery with potentially shorter recovery times. As medical technology continues to advance, cryoablation stands as a testament to the innovative approaches being developed to enhance patient outcomes and quality of life.
Title : Surgical fetal stem cells implantation in heart failure patients long term results at 14 years
Federico Benetti, Benetti Foundation, Argentina
Title : Exploring new biomarkers of cardiomyopathy
Shuping Zhong, University of Southern California, United States
Title : The development of human relaxin-2 for heart failure with preserved ejection fraction, HFpEF
Thomas Bernd Dschietzig, Relaxera GmbH & Co. KG, Germany
Title : Cancer and cardiovascular diseases: Common pathogenesis mechanisms and risk factors
Mekhman N Mamedov, National Research Center for Preventive Medicine, Russian Federation
Title : Pulse field ablation for atrial fibrillation complications: What do we know yet
Narendra Kumar, HeartbeatsZ Academy, United Kingdom
Title : Lipoprotein (a): The hidden cardiovascular risk
Syed Raza, Awali Hospital, Bahrain